Health Care/Hospital
Registrational Phase III AMPLIFY trial: Target number of participants achieved
SYDNEY, March 10, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Phase III A...
2026-03-10 21:02
6512
Zepp Health Corporation to Report Fourth Quarter and Full Year 2025 Financial Results on March 15, 2026
Earnings Call Scheduled for 9:30 p.m. ET on March 15, 2026 MILPITAS, Calif., March 10, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it will report its fourth quarter and ...
2026-03-10 20:30
5368
The 0.05 EU/mg Breakthrough: How Sino Biological ProPure™ Is Redefining the Ultra-Low Endotoxin Standard
HOUSTON, March 10, 2026 /PRNewswire/ -- While exotoxins dominate discussions of bacterial infections, endotoxins—cell wall components released upon bacterial death—are equally dangerous. These endotoxins trigger hyperinflammatory responses that spiral into endotoxemia, in which bloodstream endoto...
2026-03-10 15:22
3813
IgHM - A New Breakthrough in Immunonutrition
HO CHI MINH CITY, Vietnam, March 9, 2026 /PRNewswire/ -- With an orientated development based on scientific nutrition, VitaDairy (Vietnam) has officially introduced its new ColosBaby Lactoferrin - a nutritional formula, which is utilized with many superior nutrients such as a super-immune complex...
2026-03-09 19:13
3774
Health In Tech to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026
STUART, Fla., March 9, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the fourth quarter and full year endedDecember 31, 2025, following the close of market onWednesday, March 25, 2026. ...
2026-03-09 19:00
6335
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Atopic Dermatitis
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 9, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, and Kelun-Biotech (6990.HK) today announced ...
2026-03-09 16:32
6197
Leads Biolabs' Opamtistomig (LBL-024) Enrolls First ESCC Patient, Exploring Dual PD-L1/4-1BB Mechanism for Superior Survival Benefits in China's High-Incidence Cancer
NANJING, China, March 9, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK)announced on March 6, 2026 that the first patient has been successfully dosed in a Phase Ⅱ clinical study evaluating Opamtistomig (LBL-024), the company's core inve...
2026-03-09 14:28
4889
Global Times: Bluer skies, greener waters, healthier people: Healthy China as the NPC deputies see it
BEIJING, March 8, 2026 /PRNewswire/ -- Building a Healthy China by 2035 is a strategic decision made by the Communist Party ofChina (CPC), and the 15th Five-Year Plan period is critical to achieving this goal, Chinese President Xi Jinping said on Friday, emphasizing the need for coordinated plann...
2026-03-08 18:04
4373
Global Times: Deliver for real, and turn every policy into smiles on people's faces
BEIJING, March 7, 2026 /PRNewswire/ -- "33 million families have received child-rearing subsidies" and "an integrated elderly care service network covering urban and rural areas has taken initial shape"... At the press conference for the fourth session of the 14th National People's Congress (NPC)...
2026-03-07 21:52
5272
Global Times: Understanding 'people' at the heart of Healthy China
"Building a Healthy China by 2035 is a strategic decision made by the Communist Party ofChina (CPC) Central Committee." BEIJING, March 7, 2026 /PRNewswire/ -- On Friday afternoon, Xi Jinping, General Secretary of the CPC Central Committee, visited the members of the Chinese Peasants and Workers ...
2026-03-07 18:47
4641
CARsgen Therapeutics Announces 2025 Annual Results
SHANGHAI, March 6, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2025 Annual Results. Business Highlights * Cash and cash equivalents were around RMB1,123 million as of Decemb...
2026-03-06 20:03
9999
Insilico and TaiGen Achieve Milestone in Collaboration: Out-Licensed CKD Anemia Candidate ISM4808 Completes first human enrollment and dosing in Phase I clinical trial
CAMBRIDGE, Mass., March 5, 2026 /PRNewswire/ -- Insilico Medicine (Insilico Medicine, HKEX: 03696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), announced that ISM4808, an AI-driven PHD inhibitor for chronic kidney disease (CKD)-related anemia previou...
2026-03-06 18:53
6515
Datasea Accelerates Global Commercialization of Acoustic + AI Health Care Robots, Expanding Scalable Applications in China and International Markets
Initial Technical Service Revenue Achieved as the Company Advances Global Deployment and Chain Expansion with Strategic Partner BEIJING, March 5, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in acoustic high-tech innovation and ...
2026-03-05 22:30
4488
Cerecin Announces TEDx Talk by CEO Dr. Charles Stacey is Now Available Online
Titled "The Potential of Fasting and Diet in the Future of Medicine" Highlighting the Potential of Ketones - from Fasting, the Ketogenic diet and Pharmaceuticals - to Address Neurological Disease and Improve Brain Health DENVER, Colo., March 5, 2026 /PRNewswire/ -- Cerecin Inc., a clinical-stage ...
2026-03-05 22:28
3963
Cadonilimab Achieves 100% 24-Month OS in Complete Responders in R/M Cervical Cancer Based on Long-Term Phase II Results
HONG KONG, March 4, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the latest long-term survival analysis data from the China pivotal registrational Phase II study (COMPASSION-03/AK104-201) of cadonilimab as a monotherapy for patients with recurrent or metasta...
2026-03-05 10:26
7727
Lunit to Be Featured in 21 AI Imaging Studies on Breast Cancer and Lung Disease at ECR 2026
* 13 oral presentations included, reaffirming the clinical value of AI-based medical image analysis * Highlighting key topics such as early risk stratification based on AI abnormality scores and interval cancer classification SEOUL, South Korea, March 4, 2026 /PRNewswire/ -- Lunit (KRX:32813)...
2026-03-04 22:00
6620
Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
* Collaboration will evaluate Akeso's cadonilimab in combination with INOVIO's INO-5412 (INO-5401 plus INO-9012) as a potential treatment for glioblastoma (GBM), the most common and aggressive form of brain cancer * Novel combination therapy will be studied as part of the Phase II adaptive pl...
2026-03-04 21:52
7687
Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains
HOUSTON, March 3, 2026 /PRNewswire/ -- The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine composition, highlighting the continued spread of A(H3N2) subclade K and emerging B/Victoria lineage strains. In rapid response, Sin...
2026-03-04 09:53
6522
iClever Joins Forces with Renowned Audiologist Kellsie Busho to Champion Children's Hearing Health on World Hearing Day 2026
NEWARK, N.J., March 3, 2026 /PRNewswire/ -- As digital learning and personal audio devices become central to childhood, experts warn of rising risks of preventable hearing damage. Marking World Hearing Day, iClever, the No.1 selling kids' headphone brand in the U.S. online market, today announced...
2026-03-04 00:08
6684
Insilico Medicine and Liquid AI Announce Strategic Partnership Delivering Lightweight Scientific Foundation Models for Drug Discovery
Single 2.6B-parameter model achieves state-of-the-art performance across drug discovery benchmarks while running entirely on private pharmaceutical infrastructure CAMBRIDGE, Mass., March 3, 2026 /PRNewswire/ -- Insilico Medicine and Liquid AI today announced a partnership that creates lightweigh...
2026-03-03 22:25
6233
Week's Top Stories
Most Reposted
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
The Philippines Sets a New Standard in Muslim-Friendly Tourism
[Picked up by 287 media titles]
2026-05-26 10:30
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 281 media titles]
2026-05-20 09:15ISDN's IDI Dynamics debuts high-speed laser marker for semiconductor assembly and test (OSAT)
[Picked up by 280 media titles]
2026-05-26 08:40
Consistently recognised: Infobip named a Leader in Gartner® Magic Quadrant™ for CPaaS again
[Picked up by 279 media titles]
2026-05-21 16:31
Most Read
NYSE Content Update: Lincoln International Pops by 13% in First Day of Trade
2026-05-21 21:04
8699
Scienjoy Holding Corporation Reports Unaudited First Quarter 2026 Financial Results
2026-05-21 20:30
8419
